Demesmaeker Alice, Dufrenois Florian, Saint-Dizier Chloé, Vaiva Guillaume, Lamer Antoine, Horn Mathilde, D'Hondt Fabien
Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France.
Centre national de ressources et de résilience (Cn2r), Lille-Paris, France.
Eur Psychiatry. 2025 Jan 15;68(1):e10. doi: 10.1192/j.eurpsy.2024.1810.
The lifetime prevalence of PTSD ranges from 6 to 20% and is often associated with comorbid disorders. Despite the significant impact of PTSD, specific data on healthcare utilization related to PTSD remain limited. This study aims to characterize PTSD-related hospitalizations in France over the past decade.
This nationwide longitudinal retrospective study analyzed PTSD-related hospitalizations in France from 2013 to 2022 using the French National Hospitals Database. Data included discharge records from general and psychiatric hospitals, detailing demographics, admission/discharge dates, ICD-10 diagnoses, and hospitalization specifics.
Between 2013 and 2022, 69,108 patients underwent 125,349 hospitalizations with a PTSD diagnosis (0.4% of all inpatient cases) in France. Psychiatric facilities accounted for 74,988 hospitalizations (1% of all psychiatric inpatient cases in France), while general hospitals recorded 50,361 hospitalizations (0.02% of all non-psychiatric inpatient cases). The percentage of inpatients diagnosed with PTSD increased from 0.68 to 2.22% in psychiatric facilities and from 0.02 to 0.04% in general hospitals over the study period. Females were younger in both settings and had longer stays compared to males in psychiatric facilities. Over time, there was a decrease in median age and an increase in part-time hospitalizations in psychiatric facilities. Mood disorders, stress-related disorders, and substance use disorders were prevalent comorbidities in both settings.
This study highlights a rise in PTSD-related hospitalizations in France, particularly in psychiatric facilities and after 2019, with high rates among women and an increase in hospitalization of younger individuals. These findings highlight the necessity for improved care strategies tailored to the increasing number of younger patients with PTSD.
创伤后应激障碍（PTSD）的终生患病率在6%至20%之间，且常与共病相关。尽管PTSD有重大影响，但与PTSD相关的医疗利用的具体数据仍然有限。本研究旨在描述过去十年法国与PTSD相关的住院情况。
这项全国性纵向回顾性研究使用法国国家医院数据库分析了2013年至2022年法国与PTSD相关的住院情况。数据包括综合医院和精神病医院的出院记录，详细列出了人口统计学信息、入院/出院日期、国际疾病分类第十版（ICD-10）诊断以及住院详情。
2013年至2022年期间，法国有69108名患者因PTSD诊断接受了125349次住院治疗（占所有住院病例的0.4%）。精神科设施记录了74988次住院治疗（占法国所有精神科住院病例的1%），而综合医院记录了50361次住院治疗（占所有非精神科住院病例的0.02%）。在研究期间，精神科设施中被诊断为PTSD的住院患者比例从0.68%增加到2.22%，综合医院中从0.02%增加到0.04%。在这两种情况下，女性都比男性年轻，并且在精神科设施中的住院时间更长。随着时间的推移，精神科设施中的年龄中位数下降，部分住院治疗增加。情绪障碍、与压力相关的障碍和物质使用障碍在这两种情况下都是常见的共病。
本研究强调了法国与PTSD相关的住院治疗有所增加，特别是在精神科设施中以及2019年之后，女性比例较高，年轻个体的住院治疗有所增加。这些发现凸显了针对越来越多年轻PTSD患者改进护理策略的必要性。
